Associations of the microbiome and esophageal disease.
Microbiome
adenocarcinoma
gastroesophageal reflux disease (GERD)
Journal
Journal of thoracic disease
ISSN: 2072-1439
Titre abrégé: J Thorac Dis
Pays: China
ID NLM: 101533916
Informations de publication
Date de publication:
Aug 2019
Aug 2019
Historique:
entrez:
7
9
2019
pubmed:
7
9
2019
medline:
7
9
2019
Statut:
ppublish
Résumé
The incidence of esophageal diseases such as esophageal adenocarcinoma (EAC) and gastroesophageal reflux disease (GERD) have been increasing over the last 40 years. The esophageal microbiome appears to have a role in the development of some disease processes, and could also serve as markers of early diseases of the esophagus. A literature review was performed examining the role of the microbiome in the development of esophageal disease. In addition, the results of several studies and experiments were included in the review. Both EAC and GERD have increased in incidence over the last 40 years. Barrett's esophagus (BE) is a risk factor for EAC. Patients with BE appear to have a microbiome expression pattern distinct from patients without BE. The distinct pattern may be related to factors within the distal esophagus such as a more acidic environment, intraluminal stasis and other elements. It remains unclear whether the change in microflora leads to esophageal disease, or whether the disease process within the esophagus allows these particular organisms to experience overgrowth compared to other microflora. Patient factors such as body mass index (BMI), diet and geographic location also appear to affect the esophageal microbiome. There is an association with the esophageal microbiome and several esophageal diseases. Future studies should examine these correlations more closely. The distinct patterns may be able to serve as a marker of early disease, and possibly lead to a mechanism for the development of esophageal disease.
Identifiants
pubmed: 31489225
doi: 10.21037/jtd.2019.05.82
pii: jtd-11-S12-S1588
pmc: PMC6702393
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
S1588-S1593Subventions
Organisme : NCATS NIH HHS
ID : KL2 TR001441
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR001439
Pays : United States
Déclaration de conflit d'intérêts
Conflicts of Interest: The authors have no conflicts of interest to declare.
Références
Nat Rev Cancer. 2003 Sep;3(9):676-84
pubmed: 12951586
Gastroenterology. 2007 Jul;133(1):34-41; quiz 311
pubmed: 17631128
Gastroenterology. 2009 Aug;137(2):588-97
pubmed: 19394334
Annu Rev Med. 2011;62:361-80
pubmed: 21226616
N Engl J Med. 2011 Oct 13;365(15):1375-83
pubmed: 21995385
Cancer Causes Control. 2012 Mar;23(3):399-404
pubmed: 22271008
Int J Inflam. 2012;2012:151085
pubmed: 22577594
Clin Chem. 2013 Apr;59(4):617-28
pubmed: 23401286
Aliment Pharmacol Ther. 2013 Jun;37(11):1084-92
pubmed: 23600758
Eur Respir Rev. 2013 Sep 1;22(129):376-81
pubmed: 23997064
Environ Microbiol. 2014 Sep;16(9):2905-14
pubmed: 24112768
ISME J. 2014 Jul;8(7):1403-17
pubmed: 24500617
Gut Microbes. 2014 Mar-Apr;5(2):165-75
pubmed: 24637601
Gut. 2014 Sep;63(9):1513-21
pubmed: 24833634
Cancer J. 2014 May-Jun;20(3):207-10
pubmed: 24855009
PLoS One. 2014 Oct 08;9(10):e109350
pubmed: 25295715
Exp Ther Med. 2015 Mar;9(3):685-692
pubmed: 25667614
PLoS One. 2015 Jun 15;10(6):e0129055
pubmed: 26076489
BMC Cancer. 2016 Feb 02;16:52
pubmed: 26841926
Dig Dis Sci. 2016 Aug;61(8):2217-25
pubmed: 27068172
FEMS Microbiol Ecol. 2016 Oct;92(10):
pubmed: 27465078
Gut Microbes. 2017 Mar 4;8(2):130-142
pubmed: 28059614
Respirology. 2017 Feb;22(2):240-250
pubmed: 28102970
J Surg Oncol. 2017 Apr;115(5):564-579
pubmed: 28320055
Sci Rep. 2017 Mar 31;7:45753
pubmed: 28362001
Lancet Gastroenterol Hepatol. 2017 Jan;2(1):32-42
pubmed: 28404012
Lancet Gastroenterol Hepatol. 2017 Apr;2(4):298-312
pubmed: 28404159
Oncotarget. 2017 Jul 18;8(29):47037-47051
pubmed: 28410201
Nutrients. 2017 Jun 08;9(6):null
pubmed: 28594351
Curr Opin Pulm Med. 2017 Sep;23(5):404-410
pubmed: 28650861
Front Microbiol. 2017 Oct 13;8:1979
pubmed: 29081768
Gastroenterology. 2018 Mar;154(4):1037-1046.e2
pubmed: 29174952
Clin Med (Lond). 2017 Dec;17(6):525-529
pubmed: 29196353
Cancer Lett. 2018 Feb 28;415:40-48
pubmed: 29197615
Int J Mol Sci. 2017 Dec 16;18(12):
pubmed: 29258183
Ann Gastroenterol. 2018 Jan-Feb;31(1):8-13
pubmed: 29333062
Nutrients. 2018 Jan 29;10(2):null
pubmed: 29382137
Int J Mol Sci. 2018 Jun 17;19(6):null
pubmed: 29914188
Front Immunol. 2018 Nov 20;9:2617
pubmed: 30532751
Microbiome. 2018 Dec 17;6(1):227
pubmed: 30558669
J Clin Med. 2019 Jan 09;8(1):null
pubmed: 30634537
Gastroenterology. 2019 Aug;157(2):492-506.e2
pubmed: 30998992
Gastroenterology. 1988 Jul;95(1):216-8
pubmed: 3371618